Average Co-Inventor Count = 5.21
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (12 from 3,684 patents)
2. Skinmedica, Inc. (1 from 10 patents)
3. Women First Healthcare, Inc. (1 from 1 patent)
14 patents:
1. 10494400 - Hepatitis C virus inhibitors
2. 7968555 - Intermediates in the preparation of entecavir via carbon-silicon oxidation
3. 7786300 - Process for preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation
4. 7511139 - Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation
5. 7205402 - Synthesis of a benzoxazinone
6. 7034152 - Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
7. 7012158 - Processes for the production of α-difluoromethyl ornithine (DFMO)
8. 6730809 - Processes for the production of &agr;-difluoromethyl ornithine (DFMO)
9. 6242614 - Semi-synthesis of paclitaxel using dialkyldichlorosilanes
10. 6215000 - Crystalline complexes of baccatin III with imidazole, 2-methylimidazole or isopropanol
11. 6008347 - N-substituted 2-azetidinones
12. 5688926 - Process of preparing etoposide phosphate and etoposide
13. 5459248 - Process of preparing etoposide phosphate and etoposide
14. 5412092 - N-substituted 2-azetidinones